These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10938696)

  • 21. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran.
    Razavi Z; Moeini B; Shafiei Y; Bazmamoun H
    J Res Health Sci; 2014; 14(2):163-6. PubMed ID: 24728754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anabolic-androgenic steroids and adolescents: recent developments.
    Denham BE
    J Addict Nurs; 2012 Oct; 23(3):167-71, quuiz 172-3. PubMed ID: 24335733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of doping agents, particularly anabolic steroids, in sports and society.
    Sjöqvist F; Garle M; Rane A
    Lancet; 2008 May; 371(9627):1872-82. PubMed ID: 18514731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of stimulants and drugs of abuse in sport: the Italian experience].
    Strano Rossi S; Abate MG; Braganò MC; Botrè F
    Adicciones; 2009; 21(3):239-42. PubMed ID: 19718495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steroid use among adolescents: longitudinal findings from Project EAT.
    vandenBerg P; Neumark-Sztainer D; Cafri G; Wall M
    Pediatrics; 2007 Mar; 119(3):476-86. PubMed ID: 17332200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism and excretion of anabolic steroids in doping control--new steroids and new insights.
    Van Eenoo P; Delbeke FT
    J Steroid Biochem Mol Biol; 2006 Nov; 101(4-5):161-78. PubMed ID: 17000101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are anabolic-androgenic steroid users polysubstance users?
    Dunn M
    J Sci Med Sport; 2009 Nov; 12(6):e1-2. PubMed ID: 19119065
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevalence, knowledge and attitude of prohibited substances use (doping) among Saudi sport players.
    Al Ghobain M; Konbaz MS; Almassad A; Alsultan A; Al Shubaili M; AlShabanh O
    Subst Abuse Treat Prev Policy; 2016 Apr; 11():14. PubMed ID: 27083557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Doping--also a problem in general practice?].
    Dickhuth HH; Berg A; Baumstark M; Rokitzki L; Huonker M; Keul J
    Fortschr Med; 1989 Sep; 107(28):585-8. PubMed ID: 2613151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
    Deligiannis A; Björnstad H; Carre F; Heidbüchel H; Kouidi E; Panhuyzen-Goedkoop NM; Pigozzi F; Schänzer W; Vanhees L;
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):687-94. PubMed ID: 17001206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs.
    Larance B; Degenhardt L; Copeland J; Dillon P
    Drug Alcohol Rev; 2008 Nov; 27(6):679-86. PubMed ID: 18825549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of performance- and image-enhancing substances among recreational athletes: a quantitative analysis of inquiries submitted to the Danish anti-doping authorities.
    Bojsen-Møller J; Christiansen AV
    Scand J Med Sci Sports; 2010 Dec; 20(6):861-7. PubMed ID: 19843266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Declared use of medication in sports.
    Thuyne WV; Delbeke FT
    Clin J Sport Med; 2008 Mar; 18(2):143-7. PubMed ID: 18332689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of prevalence of "doping" among Italian athletes.
    Scarpino V; Arrigo A; Benzi G; Garattini S; La Vecchia C; Bernardi LR; Silvestrini G; Tuccimei G
    Lancet; 1990 Oct; 336(8722):1048-50. PubMed ID: 1977030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prevalence of trimetazidine use in athletes in Poland: excretion study after oral drug administration.
    Jarek A; Wójtowicz M; Kwiatkowska D; Kita M; Turek-Lepa E; Chajewska K; Lewandowska-Pachecka S; Pokrywka A
    Drug Test Anal; 2014; 6(11-12):1191-6. PubMed ID: 25421604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of doping in Flanders in comparison to the prevalence of doping in international sports.
    Van Eenoo P; Delbeke FT
    Int J Sports Med; 2003 Nov; 24(8):565-70. PubMed ID: 14598191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General practitioners and doping in sport: attitudes and experience.
    Laure P; Binsinger C; Lecerf T
    Br J Sports Med; 2003 Aug; 37(4):335-8; discussion 338. PubMed ID: 12893720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current Status of Doping in Japan Based on Japan Anti-Doping Disciplinary Panels of the Japan Anti-Doping Agency (JADA): A Suggestion on Anti-Doping Activities by Pharmacists in Japan].
    Imanishi T; Kawabata T; Takayama A
    Yakugaku Zasshi; 2017; 137(7):883-891. PubMed ID: 28674304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Doping. High-tech cheating in sport].
    Striegel H; Simon P
    Internist (Berl); 2007 Jul; 48(7):737-42. PubMed ID: 17426943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of anabolic steroid use by male and female adolescents.
    Windsor R; Dumitru D
    Med Sci Sports Exerc; 1989 Oct; 21(5):494-7. PubMed ID: 2607943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.